Cambridge, MA – Convergent Therapeutics has announced the appointment of Andrew Davis as Chief Business and Strategy Officer. About Convergent Therapeutics: Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination…
Cambridge, MA – Convergent Therapeutics has announced the appointment of Elizabeth Montgomery as Chief People Officer. About Convergent Therapeutics: Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to…
According to filings with the U.S. Securities and Exchange Commission, Convergent Therapeutics is raising up to $39,999,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philip Kantoff played a…
According to filings with the U.S. Securities and Exchange Commission, Convergent Therapeutics is raising $99,170,694.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philip Kantoff played a key role…